At PRA Health Sciences, we work side-by-side with our clients, to move drug discovery forward, and to help them develop life-saving and life- improving drugs. For more than 30 years, we’ve been helping to bring to market everything from niche treatments and therapies to blockbuster drugs. Providing comprehensive Phase I-IV biopharmaceutical drug development in over 80 countries, we are dedicated to being innovative, and to delivering unmatched scientific expertise that improves the drug development process.
We help change people’s lives for the better every single day. It’s what we are passionate about.
Investor Resources
You may also be interested in:
Case Study
PRA Revs Up Multiple Myeloma Study
A large biotech company selected PRA to conduct 2 global Phase III open-label studies to measure the safety and efficacy of a multiple myeloma drug.…
Fact Sheet
Oncology University Fact Sheet
PRA Health Sciences has responded to the industry’s urgent need to find the right CRAs for oncology research with our new Oncology University. This…
White Paper
The Patient Voice: Engaging Rare Disease Patients Improves Clinical Trial Enrollment & Retention
Clinical trials in rare diseases are complex and present unique challenges. However, patients in these trials are very vocal, with caretakers, family…